Literature DB >> 7559479

Transcriptional repression by human adenovirus E1A N terminus/conserved domain 1 polypeptides in vivo and in vitro in the absence of protein synthesis.

C Z Song1, C J Tierney, P M Loewenstein, R Pusztai, J S Symington, Q Q Tang, K Toth, A Nishikawa, S T Bayley, M Green.   

Abstract

The human adenovirus E1A 243R protein (243 residues) transcriptionally represses a set of cellular genes that regulate cellular growth and differentiation. We describe two lines of evidence that E1A repression does not require cellular protein synthesis but instead involves direct interaction with a cellular protein(s). First, E1A 243R protein represses an E1A-repressible promoter in the presence of inhibitors of protein synthesis, as shown by cell microinjection-in situ hybridization. Second, E1A 243R protein strongly represses transcription in vitro from promoters of the E1A-repressible genes, human collagenase, and rat insulin type II. Repression in vitro is promoter-specific, and an E1A polypeptide containing only the N-terminal 80 residues is sufficient for strong repression both in vivo and in vitro. By use of a series of E1A 1-80 deletion proteins, the E1A repression function was found to require two E1A sequence elements, one within the nonconserved E1A N terminus, and the second within a portion of conserved region 1 (40-80). These domains have been reported to possess binding sites for several cellular transcription regulators, including p300, Dr1, YY1, and the TBP subunit of TFIID. The in vitro transcription-repression system described here provides a powerful tool for the further analysis of molecular mechanism and the possible role of these cellular factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559479     DOI: 10.1074/jbc.270.40.23263

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Adenovirus E1A proteins are closely associated with chromatin in productively infected and transformed cells.

Authors:  Maurice Green; Ninder K Panesar; Paul M Loewenstein
Journal:  Virology       Date:  2007-11-26       Impact factor: 3.616

2.  A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.

Authors:  A Sandmöller; H Meents; H H Arnold
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

3.  Expression of the Adenovirus Early Gene 1A Transcription-Repression Domain Alone Downregulates HER2 and Results in the Death of Human Breast Cancer Cells Upregulated for the HER2 Proto-Oncogene.

Authors:  Paul M Loewenstein; Maurice Green
Journal:  Genes Cancer       Date:  2011-07

4.  Recruitment of CBP/p300, TATA-binding protein, and S8 to distinct regions at the N terminus of adenovirus E1A.

Authors:  Mozhgan Rasti; Roger J A Grand; Joe S Mymryk; Phillip H Gallimore; Andrew S Turnell
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  The adenovirus E1A N-terminal repression domain represses transcription from a chromatin template in vitro.

Authors:  Paul M Loewenstein; Shwu-Yuan Wu; Cheng-Ming Chiang; Maurice Green
Journal:  Virology       Date:  2012-04-21       Impact factor: 3.616

6.  Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation.

Authors:  Janice M Boyd; Paul M Loewenstein; Qing-quan Tang Qq; Li Yu; Maurice Green
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  The adenovirus E1A repression domain disrupts the interaction between the TATA binding protein and the TATA box in a manner reversible by TFIIB.

Authors:  C Z Song; P M Loewenstein; K Toth; Q Tang; A Nishikawa; M Green
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

8.  The adenovirus E1A oncoprotein N-terminal transcriptional repression domain enhances p300 autoacetylation and inhibits histone H3 Lys18 acetylation.

Authors:  Ling-Jun Zhao; Paul M Loewenstein; Maurice Green
Journal:  Genes Cancer       Date:  2015-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.